Apex Biotechnology

Apex Biotechnology Current Assets

Current Assets of Apex Biotechnology (1733.TW) as of Nov 22, 2026.

Current Assets

-TWD

Last updated:

Current Assets of Apex Biotechnology is 2026 - TWD. Current Assets of Apex Biotechnology was 2025 1.64 B TWD. It decreases by % lower compared to the previous year.

The Apex Biotechnology Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2014
1.49 B TWD
Jan 1, 2015
1.65 B TWD
Jan 1, 2016
1.76 B TWD
Jan 1, 2018
1.58 B TWD
Jan 1, 2019
1.77 B TWD
Jan 1, 2020
1.69 B TWD
Jan 1, 2022
1.66 B TWD
Jan 1, 2024
1.64 B TWD
The Apex Biotechnology Current Assets history
YEARCurrent AssetsYoY
1.64 BTWD-1.29%
1.66 BTWD-1.40%
1.69 BTWD-4.83%
1.77 BTWD+12.12%
1.58 BTWD-10.15%
1.76 BTWD+6.41%
1.65 BTWD+10.92%
1.49 BTWD-17.22%
1.80 BTWD+17.63%
1.53 BTWD+22.07%
1.26 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Apex Biotechnology Stock analysis

What does Apex Biotechnology do? Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apex Biotechnology stock

On Eulerpool you can find the complete historical development of Current Assets Apex Biotechnology since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Apex Biotechnology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Apex Biotechnology

All Key Metrics — Apex Biotechnology